Filing Details

Accession Number:
0001209191-13-049384
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-25 16:10:08
Reporting Period:
2013-10-24
Filing Date:
2013-10-25
Accepted Time:
2013-10-25 16:10:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197036 I Bruce Sachs C/O Vertex Pharmaceuticals Incorporated
130 Waverly St.
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-10-24 2,500 $76.80 68,910 No 4 S Direct
Common Stock Disposition 2013-10-24 5,800 $77.17 63,110 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $76.80 (range $76.10 to $76.99).
  3. Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $77.17 (range $77.00 to $77.59).